BIAF

NASDAQ · Biotechnology

Bioaffinity Technologies Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.38

-0.09 (-18.98%)

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +7,312.5% upside

Low Target $22.24

Average Target $28.39

High Target $33.42

Current Price $0.38

Current
$0.38

Target
$28.39

$22.24 $28.39 avg $33.42

Scenario Analysis

Bear Case

$22.24

5,706.8%

Low target

Base Case

$28.39

+7,312.5%

Avg target

Bull Case

$33.42

+8,625.8%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$13.50

-97.2% from high

52-Week Low

$0.51

+-25.3% from low

Target vs 52W High

$28.39

+110.3% vs high

Next Earnings Report

Aug 19, 2026

until earnings

EPS Est: $-2.14

Earnings in 4 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+2.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.5%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.6%